- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 186.95M sh |
| Long Term Debt | Q1 2025 · Mar 28, 2025 | $10.98B |
| Long Term Debt | Q1 2025 · Jan 3, 2025 | $11.08B |
| Short Term Debt | Q1 2025 · Mar 28, 2025 | $535M |
| Short Term Debt | Q1 2025 · Jan 3, 2025 | $515M |
| Cash And Equivalents | Q1 2025 · Mar 28, 2025 | $517M |
| Cash And Equivalents | Q1 2025 · Jan 3, 2025 | $615M |
| Stockholders Equity | Q1 2025 · Mar 28, 2025 | $19.13B |
| Stockholders Equity | Q1 2025 · Jan 3, 2025 | $19.51B |
| Current Liabilities | Q1 2025 · Mar 28, 2025 | $7.45B |
| Current Liabilities | Q1 2025 · Jan 3, 2025 | $7.63B |
| Total Liabilities | Q1 2025 · Mar 28, 2025 | $22.12B |
| Total Liabilities | Q1 2025 · Jan 3, 2025 | $22.42B |
| Current Assets | Q1 2025 · Mar 28, 2025 | $7.6B |
| Current Assets | Q1 2025 · Jan 3, 2025 | $8.22B |
| Total Assets | Q1 2025 · Mar 28, 2025 | $41.25B |
| Total Assets | Q1 2025 · Jan 3, 2025 | $42B |
| Shares Diluted | Q1 2025 · Mar 29, 2024 | 190.8M sh |
| Stock Repurchased | Q1 2025 · Mar 29, 2024 | $233M |
| Dividends Paid | Q1 2025 · Mar 29, 2024 | $224M |
| Capex | Q1 2025 · Mar 29, 2024 | $115M |
| Operating Cash Flow | Q1 2025 · Mar 29, 2024 | −$104M |
| Eps Diluted | Q1 2025 · Mar 29, 2024 | $1.48 |
| Eps Basic | Q1 2025 · Mar 29, 2024 | $1.49 |
| Sga Expense | Q1 2025 · Mar 29, 2024 | $970M |
| Net Income | Q1 2025 · Mar 29, 2024 | $283M |
| Operating Income | Q1 2025 · Mar 29, 2024 | $378M |
| Cost Of Revenue | Q1 2025 · Mar 29, 2024 | $3.86B |
| Revenue | Q1 2025 · Mar 29, 2024 | $5.21B |